Mesco Pharmaceuticals Ltd. reported audited standalone earnings results for the fourth quarter and year ended March 31, 2018. For the quarter, the company reported loss before tax of INR 129,560 as compared to INR 2,341,854 for the same period last year. Loss for the period from Continuing Operations was INR 129,560 as compared to INR 2,351,559 for the same period last year. Loss for the period was INR 129,560 as compared to INR 2,351,559 for the same period last year. Basic and Diluted loss per share was INR 0.01 as compared to INR 0.12 for the same period last year. For the year, the company reported loss before tax of INR 873,490 as compared to INR 2,579,969 for the same period last year. Loss for the period from Continuing Operations was INR 879,490 as compared to INR 2,589,674 for the same period last year. Loss for the period was INR 873,490 as compared to INR 2,589,674 for the same period last year. Basic and Diluted loss per share was INR 0.04 as compared to INR 0.13 for the same period last year.